Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.
Vallejo M, Muñiz P, Kwon M, Solán L, Bailén R, Carbonell D, Chicano M, Suárez-González J, Catalán P, Bellón JM, Triviño JC, Dorado N, Gallardo D, Díez-Martín JL, Ramírez N, Martínez-Laperche C, Buño I. Vallejo M, et al. Ann Hematol. 2022 Jul;101(7):1567-1576. doi: 10.1007/s00277-022-04841-8. Epub 2022 May 7. Ann Hematol. 2022. PMID: 35525883 Free PMC article.
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya A, Pérez-García A, Brunet S, Solano C, Buño I, Guillem V, Martínez-Laperche C, Sanz G, Barrenetxea C, Martínez C, Tuset E, Lloveras N, Coll R, Guardia R, González Y, Roncero JM, Bustins A, Gardella S, Fernández C, Buch J, Gallardo D; GvHD/Immunotherapy committee of the Spanish Group for Hematopoietic Transplant (GETH). Bosch-Vizcaya A, et al. Biol Blood Marrow Transplant. 2012 Jan;18(1):100-5. doi: 10.1016/j.bbmt.2011.05.021. Epub 2011 Jun 12. Biol Blood Marrow Transplant. 2012. PMID: 21703972 Free article.
Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
Kwon M, Martínez-Laperche C, Infante M, Carretero F, Balsalobre P, Serrano D, Gayoso J, Pérez-Corral A, Anguita J, Díez-Martín JL, Buño I. Kwon M, et al. Biol Blood Marrow Transplant. 2012 Aug;18(8):1235-42. doi: 10.1016/j.bbmt.2012.01.012. Epub 2012 Jan 25. Biol Blood Marrow Transplant. 2012. PMID: 22281301 Free article.
Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.
Rodríguez-Macías G, Martínez-Laperche C, Gayoso J, Noriega V, Serrano D, Balsalobre P, Muñoz-Martínez C, Díez-Martín JL, Buño I. Rodríguez-Macías G, et al. Hum Pathol. 2013 Aug;44(8):1696-9. doi: 10.1016/j.humpath.2013.01.001. Epub 2013 Mar 1. Hum Pathol. 2013. PMID: 23465275
A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT.
Martín-Antonio B, Suarez-Lledo M, Arroyes M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Gallardo D, Bosch A, Buño I, Martínez-Laperche C, Jiménez-Velasco A, de la Cámara R, Brunet S, Nieto JB, Urbano-Ispizua A. Martín-Antonio B, et al. Bone Marrow Transplant. 2013 Sep;48(9):1205-11. doi: 10.1038/bmt.2013.43. Epub 2013 Apr 1. Bone Marrow Transplant. 2013. PMID: 23542224
A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.
Guillem V, Hernández-Boluda JC, Gallardo D, Buño I, Bosch A, Martínez-Laperche C, de la Cámara R, Brunet S, Martin C, Nieto JB, Martínez C, Pérez A, Montoro J, Garcia-Noblejas A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH). Guillem V, et al. Am J Hematol. 2013 Oct;88(10):883-9. doi: 10.1002/ajh.23523. Epub 2013 Aug 1. Am J Hematol. 2013. PMID: 23813863 Free article. Clinical Trial.
Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation.
Bastos-Oreiro M, Perez-Corral A, Martínez-Laperche C, Bento L, Pascual C, Kwon M, Balsalobre P, Muñoz C, Buces E, Serrano D, Gayoso J, Buño I, Anguita J, Diéz-Martín JL. Bastos-Oreiro M, et al. Eur J Haematol. 2014 Sep;93(3):239-46. doi: 10.1111/ejh.12336. Epub 2014 Apr 29. Eur J Haematol. 2014. PMID: 24702162
Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT.
Bosch-Vizcaya A, Rodriguez-Romanos R, Nieto JB, de la Cámara R, Brunet S, Vallejo C, Osca-Gelis G, Martínez-Laperche C, Buño I, Urbano-Ispizúa Á, González M, Jiménez-Velasco A, Gallardo D. Bosch-Vizcaya A, et al. Bone Marrow Transplant. 2015 Feb;50(2):298-300. doi: 10.1038/bmt.2014.234. Epub 2014 Oct 20. Bone Marrow Transplant. 2015. PMID: 25330223 No abstract available.
Achievement of early complete donor chimerism in CD25+-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation.
Martínez-Laperche C, Noriega V, Kwon M, Balsalobre P, González-Rivera M, Serrano D, Anguita J, Gayoso J, Díez-Martín JL, Buño I. Martínez-Laperche C, et al. Exp Hematol. 2015 Jan;43(1):4-13.e1. doi: 10.1016/j.exphem.2014.09.003. Epub 2014 Oct 28. Exp Hematol. 2015. PMID: 25450515 Free article.
65 results